{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:33:31Z","timestamp":1785900811160,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04105-6","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T16:19:44Z","timestamp":1719505184000},"page":"3845-3855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factors of disease activity and renal damage in patients with systemic lupus erythematosus"],"prefix":"10.1007","volume":"56","author":[{"given":"HuiLing","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QianYu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MengMeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiHua","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0109-8786","authenticated-orcid":false,"given":"XiaoYan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"4","key":"4105_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/ndt\/gfx189","volume":"33","author":"MM O'Shaughnessy","year":"2018","unstructured":"O\u2019Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC (2018) Glomerular disease frequencies by race, sex and region: results from the international kidney biopsy survey. Nephrol Dial Transpl 33(4):661\u2013669. https:\/\/doi.org\/10.1093\/ndt\/gfx189","journal-title":"Nephrol Dial Transpl"},{"issue":"10029","key":"4105_CR2","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/s0140-6736(16)30266-5","volume":"387","author":"R Barnett","year":"2016","unstructured":"Barnett R (2016) Systemic lupus erythematosus. Lancet 387(10029):1711. https:\/\/doi.org\/10.1016\/s0140-6736(16)30266-5","journal-title":"Lancet"},{"issue":"9957","key":"4105_CR3","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/s0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384(9957):1878\u20131888. https:\/\/doi.org\/10.1016\/s0140-6736(14)60128-8","journal-title":"Lancet"},{"issue":"8","key":"4105_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrneph.2017.85","volume":"13","author":"F Yu","year":"2017","unstructured":"Yu F, Haas M, Glassock R, Zhao MH (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 13(8):483\u2013495. https:\/\/doi.org\/10.1038\/nrneph.2017.85","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4105_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2478\/rir-2020-0009","volume":"1","author":"M Li","year":"2020","unstructured":"Li M, Zhao Y, Zhang Z et al (2020) 2020 Chinese Guidelines for the diagnosis and treatment of systemic lupus erythematosus. Rheumatol Immunol Res 1(1):5\u201323. https:\/\/doi.org\/10.2478\/rir-2020-0009","journal-title":"Rheumatol Immunol Res"},{"issue":"6","key":"4105_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1177\/0961203319846388","volume":"28","author":"\u00d6 Dahlstr\u00f6m","year":"2019","unstructured":"Dahlstr\u00f6m \u00d6, Sj\u00f6wall C (2019) The diagnostic accuracies of the 2012 SLICC criteria and the proposed EULAR\/ACR criteria for systemic lupus erythematosus classification are comparable. Lupus 28(6):778\u2013782. https:\/\/doi.org\/10.1177\/0961203319846388","journal-title":"Lupus"},{"issue":"9","key":"4105_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3760\/cma.j.cn112138-20210609-00410","volume":"60","author":"H Zhang","year":"2021","unstructured":"Zhang H, Yang NS, Lu J et al (2021) Recommendations for the diagnosis and management of lupus nephritis in China. Zhonghua Nei Ke Za Zhi 60(9):784\u2013790. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20210609-00410","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"(suppl_1)","key":"4105_CR8","doi-asserted-by":"publisher","first-page":"i71","DOI":"10.1093\/ndt\/gfw300","volume":"32","author":"DJ Birmingham","year":"2017","unstructured":"Birmingham DJ, Merchant M, Waikar SS, Nagaraja H, Klein JB, Rovin BH (2017) Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise. Nephrol Dial Transpl 32((suppl_1)):i71\u2013i79. https:\/\/doi.org\/10.1093\/ndt\/gfw300","journal-title":"Nephrol Dial Transpl"},{"issue":"17","key":"4105_CR9","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/01.Cir.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108(17):2154\u20132169. https:\/\/doi.org\/10.1161\/01.Cir.0000095676.90936.80","journal-title":"Circulation"},{"issue":"3","key":"4105_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/0961203320983906","volume":"30","author":"A Wakamatsu","year":"2021","unstructured":"Wakamatsu A, Sato H, Kaneko Y et al (2021) Association of coexisting anti-ribosomal P and anti-dsDNA antibodies with histology and renal prognosis in lupus nephritis patients. Lupus 30(3):448\u2013458. https:\/\/doi.org\/10.1177\/0961203320983906","journal-title":"Lupus"},{"key":"4105_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clim.2016.09.002","volume":"185","author":"S Yung","year":"2017","unstructured":"Yung S, Chan TM (2017) Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis. Clin Immunol 185:40\u201350. https:\/\/doi.org\/10.1016\/j.clim.2016.09.002","journal-title":"Clin Immunol"},{"issue":"9","key":"4105_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","volume":"73","author":"J Leffler","year":"2014","unstructured":"Leffler J, Bengtsson AA, Blom AM (2014) The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis 73(9):1601\u20131606. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205287","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4105_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D et al (2019) 2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78(9):1151\u20131159. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214819","journal-title":"Ann Rheum Dis"},{"key":"4105_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108272","volume":"239","author":"M Sugahara","year":"2022","unstructured":"Sugahara M, Tanaka T, Nangaku M (2022) Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors. Pharmacol Ther 239:108272. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108272","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4105_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/bjh.15895","volume":"186","author":"GA Scholz","year":"2019","unstructured":"Scholz GA, Leichtle AB, Scherer A et al (2019) The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis. Br J Haematol 186(1):101\u2013112. https:\/\/doi.org\/10.1111\/bjh.15895","journal-title":"Br J Haematol"},{"issue":"9","key":"4105_CR16","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/jci20945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V et al (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113(9):1271\u20131276. https:\/\/doi.org\/10.1172\/jci20945","journal-title":"J Clin Invest"},{"issue":"1","key":"4105_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1182\/blood-2006-07-033969","volume":"109","author":"MV Verga Falzacappa","year":"2007","unstructured":"Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109(1):353\u2013358. https:\/\/doi.org\/10.1182\/blood-2006-07-033969","journal-title":"Blood"},{"issue":"6","key":"4105_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3324\/haematol.10794","volume":"92","author":"H Kawabata","year":"2007","unstructured":"Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, Uchiyama T (2007) Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman\u2019s disease. Haematologica 92(6):857\u2013858. https:\/\/doi.org\/10.3324\/haematol.10794","journal-title":"Haematologica"},{"issue":"4","key":"4105_CR19","doi-asserted-by":"publisher","first-page":"R182","DOI":"10.1186\/ar4012","volume":"14","author":"K Vanarsa","year":"2012","unstructured":"Vanarsa K, Ye Y, Han J, Xie C, Mohan C, Wu T (2012) Inflammation associated anemia and ferritin as disease markers in SLE. Arthritis Res Ther 14(4):R182. https:\/\/doi.org\/10.1186\/ar4012","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"4105_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41418-017-0003-5","volume":"25","author":"MF Manchinu","year":"2018","unstructured":"Manchinu MF, Brancia C, Caria CA et al (2018) Deficiency in interferon type 1 receptor improves definitive erythropoiesis in Klf1 null mice. Cell Death Differ 25(3):589\u2013599. https:\/\/doi.org\/10.1038\/s41418-017-0003-5","journal-title":"Cell Death Differ"},{"issue":"6","key":"4105_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5414\/cnp67366","volume":"67","author":"M Espinosa","year":"2007","unstructured":"Espinosa M, Arenas MD, Aumente MD et al (2007) Anemia associated with pegylated interferon-alpha2a and alpha2b therapy in hemodialysis patients. Clin Nephrol 67(6):366\u2013373. https:\/\/doi.org\/10.5414\/cnp67366","journal-title":"Clin Nephrol"},{"issue":"3","key":"4105_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/ard.59.3.217","volume":"59","author":"M Voulgarelis","year":"2000","unstructured":"Voulgarelis M, Kokori SI, Ioannidis JP, Tzioufas AG, Kyriaki D, Moutsopoulos HM (2000) Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis 59(3):217\u2013222. https:\/\/doi.org\/10.1136\/ard.59.3.217","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4105_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/0022-3859.188550","volume":"63","author":"V Umare","year":"2017","unstructured":"Umare V, Nadkarni A, Nadkar M et al (2017) Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients? J Postgrad Med 63(2):92\u201395. https:\/\/doi.org\/10.4103\/0022-3859.188550","journal-title":"J Postgrad Med"},{"issue":"5","key":"4105_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251554","volume":"16","author":"A Tokuyama","year":"2021","unstructured":"Tokuyama A, Kanda E, Itano S et al (2021) Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia. PLoS ONE 16(5):e0251554. https:\/\/doi.org\/10.1371\/journal.pone.0251554","journal-title":"PLoS ONE"},{"issue":"8432","key":"4105_CR25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/s0140-6736(85)91447-3","volume":"1","author":"A Fleck","year":"1985","unstructured":"Fleck A, Raines G, Hawker F et al (1985) Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1(8432):781\u2013784. https:\/\/doi.org\/10.1016\/s0140-6736(85)91447-3","journal-title":"Lancet"},{"issue":"2","key":"4105_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters PB, Wolfe RR, Shenkin A (2019) Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr 43(2):181\u2013193. https:\/\/doi.org\/10.1002\/jpen.1451","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"4105_CR27","first-page":"246","volume":"5","author":"S Han","year":"2013","unstructured":"Han S, Vaziri ND, Gollapudi P, Kwok V, Moradi H (2013) Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome. Am J Transl Res 5(2):246\u2013253","journal-title":"Am J Transl Res"},{"issue":"5","key":"4105_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11926-022-01069-3","volume":"24","author":"GK Ramos","year":"2022","unstructured":"Ramos GK, Goldfarb DS (2022) Update on Uric Acid and the Kidney. Curr Rheumatol Rep 24(5):132\u2013138. https:\/\/doi.org\/10.1007\/s11926-022-01069-3","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"4105_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.ajkd.2017.08.017","volume":"71","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS (2018) Uric acid and the risks of kidney failure and death in individuals with CKD. Am J Kidney Dis 71(3):362\u2013370. https:\/\/doi.org\/10.1053\/j.ajkd.2017.08.017","journal-title":"Am J Kidney Dis"},{"key":"4105_CR30","doi-asserted-by":"publisher","first-page":"5817348","DOI":"10.1155\/2020\/5817348","volume":"2020","author":"HY Su","year":"2020","unstructured":"Su HY, Yang C, Liang D, Liu HF (2020) Research advances in the mechanisms of hyperuricemia-induced renal injury. Biomed Res Int 2020:5817348. https:\/\/doi.org\/10.1155\/2020\/5817348","journal-title":"Biomed Res Int"},{"key":"4105_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105209","volume":"161","author":"P Balakumar","year":"2020","unstructured":"Balakumar P, Alqahtani A, Khan NA, Mahadevan N, Dhanaraj SA (2020) Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: pathologic implications and putative pharmacologic targets. Pharmacol Res 161:105209. https:\/\/doi.org\/10.1016\/j.phrs.2020.105209","journal-title":"Pharmacol Res"},{"issue":"1","key":"4105_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-000366","volume":"7","author":"C Elera-Fitzcarrald","year":"2020","unstructured":"Elera-Fitzcarrald C, Re\u00e1tegui-Sokolova C, Gamboa-Cardenas RV et al (2020) Serum uric acid is associated with damage in patients with systemic lupus erythematosus. Lupus Sci Med 7(1):e000366. https:\/\/doi.org\/10.1136\/lupus-2019-000366","journal-title":"Lupus Sci Med"},{"issue":"4","key":"4105_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10067-017-3538-4","volume":"36","author":"C Re\u00e1tegui-Sokolova","year":"2017","unstructured":"Re\u00e1tegui-Sokolova C, Ugarte-Gil MF, Gamboa-C\u00e1rdenas RV et al (2017) Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients. Clin Rheumatol 36(4):845\u2013852. https:\/\/doi.org\/10.1007\/s10067-017-3538-4","journal-title":"Clin Rheumatol"},{"issue":"159","key":"4105_CR34","first-page":"49","volume":"30","author":"Y Wang","year":"2020","unstructured":"Wang Y, Yu H, He J (2020) Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases. Discov Med 30(159):49\u201356","journal-title":"Discov Med"},{"issue":"1","key":"4105_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12944-020-01232-8","volume":"19","author":"B Zhou","year":"2020","unstructured":"Zhou B, Xia Y, She J (2020) Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study. Lipids Health Dis 19(1):40. https:\/\/doi.org\/10.1186\/s12944-020-01232-8","journal-title":"Lipids Health Dis"},{"key":"4105_CR36","doi-asserted-by":"publisher","unstructured":"Kochan Z, Szupryczynska N, Malgorzewicz S, Karbowska J (2021) Dietary Lipids and Dyslipidemia in Chronic Kidney Disease. Nutrients 13 (9) https:\/\/doi.org\/10.3390\/nu13093138","DOI":"10.3390\/nu13093138"},{"key":"4105_CR37","doi-asserted-by":"publisher","unstructured":"Liu Q, Xiao JJ, Wang S, et al. (2022) Paraoxonase 1 Ameliorates Renal Lipotoxicity by Activating Lipophagy and Inhibiting Pyroptosis. Am J Patholhttps:\/\/doi.org\/10.1016\/j.ajpath.2022.07.011","DOI":"10.1016\/j.ajpath.2022.07.011"},{"issue":"2","key":"4105_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall AR, Yvan-Charvet L (2015) Cholesterol, inflammation and innate immunity. Nat Rev Immunol 15(2):104\u2013116. https:\/\/doi.org\/10.1038\/nri3793","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"4105_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneph.2009.184","volume":"5","author":"XZ Ruan","year":"2009","unstructured":"Ruan XZ, Varghese Z, Moorhead JF (2009) An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol 5(12):713\u2013721. https:\/\/doi.org\/10.1038\/nrneph.2009.184","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4105_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/cs20160421","volume":"131","author":"S Yung","year":"2017","unstructured":"Yung S, Ng CY, Au KY et al (2017) Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation. Clin Sci (Lond) 131(1):49\u201367. https:\/\/doi.org\/10.1042\/cs20160421","journal-title":"Clin Sci (Lond)"},{"key":"4105_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109213","volume":"248","author":"AA Alli","year":"2023","unstructured":"Alli AA, Desai D, Elshika A et al (2023) Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis. Clin Immunol 248:109213. https:\/\/doi.org\/10.1016\/j.clim.2022.109213","journal-title":"Clin Immunol"},{"issue":"7","key":"4105_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneph.2017.72","volume":"13","author":"EF Carney","year":"2017","unstructured":"Carney EF (2017) Lupus nephritis: Cholesterol accumulation in DCs promotes autoimmunity. Nat Rev Nephrol 13(7):383. https:\/\/doi.org\/10.1038\/nrneph.2017.72","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"4105_CR43","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ki.2010.525","volume":"79","author":"HN Reich","year":"2011","unstructured":"Reich HN, Gladman DD, Urowitz MB et al (2011) Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney Int 79(8):914\u2013920. https:\/\/doi.org\/10.1038\/ki.2010.525","journal-title":"Kidney Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04105-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04105-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04105-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T03:07:36Z","timestamp":1730776056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04105-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4105"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04105-6","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest exists in the submission of this manuscript, and this manuscript is approved by all authors for publication. All the authors listed have approved the manuscript that is enclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Medical Ethics Committee of Zhongnan Hospital of Wuhan University (authorization number 2022091\u00a0K).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consents have been obtained from all the patients involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}